ABT 578,
ABT-578,
ABT578,
zotarilumus,
zotarolimus,
Zotarolimus,
ABT-578,
221877-54-9,
UNII-H4GXR80IZE,
H4GXR80IZE,
CHEMBL219410,
ABT 578,
A 179578,
ABT578,
Zotarolimus(ABT-578),
Zatarolimus,
zotarolimus-abt-578,
Zotarolimus [USAN:INN],
Zotarolimus (ABT-578),
Zotarolimus; ABT-578,
SCHEMBL67389,
GTPL7974,
CHEBI:135897,
C52H79N5O12,
EX-A2216,
BDBM50174276,
MFCD09752954,
s7091,
ZINC169677012,
CS-5715,
NCGC00386351-01,
BC252815,
HY-12424,
X7264,
J-014574,
Rapamycin, 42-deoxy-42-(1H-tetrazol-1-yl)-, (42S)-,
(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-19,30-dimethoxy-12-[(2R)-1-[(1S,3R,4S)-3-methoxy-4-(1H-1,2,3,4-tetrazol-1-yl)cyclohexyl]propan-2-yl]-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.0^{4,9}]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone,
Endeavor,
cc-709,